Rare diseases
Investigational molecules
Locations
Back to Denmark303 clinical trials in Herlev, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
DenmarkStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
DenmarkEfficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial
DenmarkA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
DenmarkTesting allogeneic adipose tissue-derived mesenchymal stromal cells in patients with recently diagnosed non-ischemic heart failure with reduced ejection fraction
DenmarkA Study of GSK4524101 and Niraparib for Adults with Advanced Solid Tumors or Metastatic Breast Cancer with BRCA Gene Changes
DenmarkStudy of Topical Donepezil Hydrochloride Cream for Safety and Effectiveness in Adult Patients with Acne Vulgaris
DenmarkStudy of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy
DenmarkStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
DenmarkStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
DenmarkStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
DenmarkLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in endometrial, prostate, and bladder cancers. Studies are evaluating novel combination therapies and immunological approaches.
Research aims to improve treatment outcomes and survival rates through targeted therapeutic approaches.
Comprehensive research into heart failure prevention and treatment of metabolic conditions, including studies on innovative drug combinations and biomarker-targeted approaches.
Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.
Studies examining vaccine effectiveness and preventive treatments, particularly in meningococcal and varicella infections. Research includes both pediatric and adult populations.
Emphasis on developing safe and effective preventive measures for infectious diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
